Nrf2 protection against liver injury produced by various hepatotoxicants.
about
Cadmium Protection Strategies--A Hidden Trade-Off?Role of redoximiRs in fibrogenesisRedox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesOxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant TransformationReactive oxygen species and fibrosis: further evidence of a significant liaisonMaotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in miceInflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- MiceGenetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout miceOverexpression of Nrf2 protects against microcystin-induced hepatotoxicity in mice.Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2.Differential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in miceRecql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice.Protective effect of wild ginseng cambial meristematic cells on d-galactosamine-induced hepatotoxicity in rats.Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney.Sympathetic Nervous System Control of Carbon Tetrachloride-Induced Oxidative Stress in Liver through α-Adrenergic Signaling.Mitochondrial permeabilization without caspase activation mediates the increase of basal apoptosis in cells lacking Nrf2.The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity.The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.NADPH Oxidases in Chronic Liver DiseasesNaturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury.Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity.Succinate: An initiator in tumorigenesis and progression.Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite.In vivo siRNA delivery of Keap1 modulates death and survival signaling pathways and attenuates concanavalin-A-induced acute liver injury in mice.Fast food diet-induced non-alcoholic fatty liver disease exerts early protective effect against acetaminophen intoxication in mice.Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis.Liraglutide reduces hepatic glucolipotoxicity‑induced liver cell apoptosis through NRF2 signaling in Zucker diabetic fatty rats.Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae.Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy
P2860
Q26775119-475A9D34-A44B-4729-A577-516BFB1FE67FQ26776555-B7B91E4E-CC59-4CDF-B7E9-B11933FD610AQ26786129-A875548A-6DB5-47B1-9711-DA33F720F785Q26799616-4DB02155-C088-41D6-8140-FD74D18B6C82Q28077930-7FEDCB8D-9D66-4098-B64C-327B4FAF1E3EQ28541726-2188E262-0560-4AF6-BECF-E69490893F47Q28552676-97B1C21B-578A-45CE-ADE0-7EE576C767B6Q33779962-16D47A65-A3F8-4195-8FFC-26E2E4B53F5DQ35131144-28AEAE71-5CA0-442C-A76B-349B248C7D7DQ35243790-204B38A1-5586-4275-8C66-2B458973B3D4Q35596350-075FDE1A-A0AC-456B-9F45-790F19CABAF0Q36085580-F7808BDC-5E7A-44B1-9F50-2F6A87499E91Q36122690-F69264B1-70A1-49B8-8787-25AF61257248Q36364169-25AA6F50-5372-47A0-BA88-AA8977EE0847Q36424166-9F7F97D7-9876-4AC1-964A-90701EAA9375Q37000710-2C7BA87B-DA0A-4B3D-8812-B2801B77BE06Q37689226-0933D372-4976-48FD-A740-BFA61A3C4FE1Q38539752-5AC30665-FE1D-4CAC-9B70-EC53BE0DDD6EQ38599090-49B920C5-DDEF-44A3-95A5-8D32B2D719D4Q39094306-20D20239-E667-4B4C-B7FC-86EC875D761EQ40146386-1A69937E-BBF8-4284-B8A6-48A5AC85731BQ41593409-A2869988-D7C0-479E-BC43-5E34ACE2287FQ41628271-141638C6-806A-4146-8F82-64B202272041Q41679179-737C2ECB-C1CA-4A03-BCDC-D61CAC24DB56Q42837335-97097C14-9CAC-4CC1-90F8-F4B2330AD937Q47123699-02D250AF-3C9B-4B78-BCE5-A1092298F690Q47898949-F3A6CCBD-9158-4E9B-A794-83A93FC0DDDEQ51768533-00922D2C-D641-4A5C-93F7-F3E110DD3166Q54946966-1AE8A097-3ED3-4B43-A145-D178BB0CC7B1Q55450574-288727CB-E69A-46C3-99E7-B30C93D78218Q58699616-1527530A-B42A-47FB-A4BA-8DC0D88DFE09
P2860
Nrf2 protection against liver injury produced by various hepatotoxicants.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Nrf2 protection against liver injury produced by various hepatotoxicants.
@en
type
label
Nrf2 protection against liver injury produced by various hepatotoxicants.
@en
prefLabel
Nrf2 protection against liver injury produced by various hepatotoxicants.
@en
P2093
P2860
P356
P1476
Nrf2 protection against liver injury produced by various hepatotoxicants.
@en
P2093
Curtis D Klaassen
Edugie Ekuase
Kai Connie Wu
Yuan-Fu Lu
P2860
P304
P356
10.1155/2013/305861
P577
2013-05-23T00:00:00Z